Search

Haejin S. Park

Examiner (ID: 2263, Phone: (571)270-5258 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1614, 1611, 1615
Total Applications
830
Issued Applications
412
Pending Applications
109
Abandoned Applications
336

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14649169 [patent_doc_number] => 20190231713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => METHODS FOR TREATING OR PREVENTING ORGANOPHOSPHATE POISONING [patent_app_type] => utility [patent_app_number] => 16/333685 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333685 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333685
Methods for treating or preventing organophosphate poisoning Sep 17, 2017 Issued
Array ( [id] => 16703215 [patent_doc_number] => 10953130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Solid hemostatic composition and methods of making the same [patent_app_type] => utility [patent_app_number] => 15/692654 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6160 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692654 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/692654
Solid hemostatic composition and methods of making the same Aug 30, 2017 Issued
Array ( [id] => 12091131 [patent_doc_number] => 20170348224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR MUCOSAL DELIVERY' [patent_app_type] => utility [patent_app_number] => 15/682764 [patent_app_country] => US [patent_app_date] => 2017-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26605 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682764 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/682764
Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery Aug 21, 2017 Issued
Array ( [id] => 14892163 [patent_doc_number] => 20190289847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => SUSTAINED RELEASE FIBERS [patent_app_type] => utility [patent_app_number] => 16/334626 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334626 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/334626
SUSTAINED RELEASE FIBERS Aug 8, 2017 Abandoned
Array ( [id] => 17080429 [patent_doc_number] => 20210275435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => COMPOSITION FOR INHIBITING SEBUM SECRETION COMPRISING PEACH SPROUT EXTRACT [patent_app_type] => utility [patent_app_number] => 16/321782 [patent_app_country] => US [patent_app_date] => 2017-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321782 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321782
Composition for inhibiting sebum secretion comprising peach sprout extract Jul 24, 2017 Issued
Array ( [id] => 12029371 [patent_doc_number] => 20170319470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/658965 [patent_app_country] => US [patent_app_date] => 2017-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15008 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658965 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/658965
METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS Jul 24, 2017 Abandoned
Array ( [id] => 17936950 [patent_doc_number] => 11471382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Emulsion with matte effects and excellent texture [patent_app_type] => utility [patent_app_number] => 16/302905 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18208 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302905 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302905
Emulsion with matte effects and excellent texture Jul 17, 2017 Issued
Array ( [id] => 12023709 [patent_doc_number] => 20170313808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'BIOACTIVE POLYMERIC LIQUID FORMULATIONS OF ABSORBABLE, SEGMENTED APLIPHATIC POLYURETHANE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/652135 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7826 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652135 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/652135
BIOACTIVE POLYMERIC LIQUID FORMULATIONS OF ABSORBABLE, SEGMENTED APLIPHATIC POLYURETHANE COMPOSITIONS Jul 16, 2017 Abandoned
Array ( [id] => 12125016 [patent_doc_number] => 20180008603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN' [patent_app_type] => utility [patent_app_number] => 15/645015 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7694 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645015 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/645015
PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN Jul 9, 2017 Abandoned
Array ( [id] => 15678175 [patent_doc_number] => 20200093751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-26 [patent_title] => CHEMOPROTECTIVE/CHEMOACTIVE NANODROPLETS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/313929 [patent_app_country] => US [patent_app_date] => 2017-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8270 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/313929
CHEMOPROTECTIVE/CHEMOACTIVE NANODROPLETS AND METHODS OF USE THEREOF Jun 26, 2017 Abandoned
Array ( [id] => 16640761 [patent_doc_number] => 10918582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-16 [patent_title] => Liquid mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a niacinamide compound, and cosmetic composition containing same [patent_app_type] => utility [patent_app_number] => 16/311906 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1675 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311906 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311906
Liquid mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a niacinamide compound, and cosmetic composition containing same Jun 22, 2017 Issued
Array ( [id] => 16498913 [patent_doc_number] => 10864280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Nanodroplet compositions for the efficient delivery of anti-cancer agents [patent_app_type] => utility [patent_app_number] => 16/308115 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10369 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308115 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308115
Nanodroplet compositions for the efficient delivery of anti-cancer agents Jun 8, 2017 Issued
Array ( [id] => 11954620 [patent_doc_number] => 20170258768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'ONDANSETRON EXTENDED RELEASE SOLID DOSAGE FORMS FOR TREATING EITHER NAUSEA, VOMITING OR DIARRHEA SYMPTOMS' [patent_app_type] => utility [patent_app_number] => 15/606650 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34022 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606650 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/606650
Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome May 25, 2017 Issued
Array ( [id] => 11942089 [patent_doc_number] => 20170246239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/597028 [patent_app_country] => US [patent_app_date] => 2017-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4906 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597028 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/597028
ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE May 15, 2017 Abandoned
Array ( [id] => 17741512 [patent_doc_number] => 11389559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Wound dressing or dermal patch [patent_app_type] => utility [patent_app_number] => 16/302415 [patent_app_country] => US [patent_app_date] => 2017-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7338 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302415 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302415
Wound dressing or dermal patch May 14, 2017 Issued
Array ( [id] => 11935171 [patent_doc_number] => 20170239319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/589293 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4889 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589293 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/589293
ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE May 7, 2017 Abandoned
Array ( [id] => 11935169 [patent_doc_number] => 20170239317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/589271 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4979 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589271 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/589271
ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE May 7, 2017 Abandoned
Array ( [id] => 11977397 [patent_doc_number] => 20170281551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION' [patent_app_type] => utility [patent_app_number] => 15/496728 [patent_app_country] => US [patent_app_date] => 2017-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14001 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496728 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/496728
SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION Apr 24, 2017 Abandoned
Array ( [id] => 11850651 [patent_doc_number] => 20170225143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY' [patent_app_type] => utility [patent_app_number] => 15/493745 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10088 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493745 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/493745
METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY Apr 20, 2017 Abandoned
Array ( [id] => 11755917 [patent_doc_number] => 20170202784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION' [patent_app_type] => utility [patent_app_number] => 15/472525 [patent_app_country] => US [patent_app_date] => 2017-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 33822 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472525 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/472525
CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION Mar 28, 2017 Abandoned
Menu